Skip Navigation Links

Bookmark and Share
New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients

on 9/14/2021
Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more than 20 years ZEPZELCA approval granted under a provisional regulatory pathway ...

Full "IntellAsia: Resources" article

Disclaimer | Terms Of Use And Privacy Statement

© Metals News. All rights reserved.